Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Results may not be generalisable to the community
| The first 150 words of the full text of this article appear below. |
EDITOR
The hip protector trial reported by Meyer et al is
methodologically a notable improvement on previous hip protector trials.1 However, some methodological shortcomings affect
the study, and issues arise about its generalisability to people at high risk who are not resident in nursing homes.
An important problem, not noted by the authors, is that the study
groups have differential loss to follow up. In the intervention group
64% of the participants completed the 18 month follow up compared with
only 57% of the controls (P=0.04). This difference can introduce
selection bias and could give a false estimate of effectiveness. In
addition, there seems to be some evidence that the control group may
have been frailer than the intervention group as the death rate was
somewhat greater and this may have explained the higher incidence of
falls in the control group. These differences could explain some of the
apparent effectiveness
UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care